Efficacy of a Shortened Oral Antibiotic Bowel Decontamination in Minimally Invasive Surgery for Diverticular Disease

Josefine Schardey1, Thomas von Ahnen2, Alexander Crispin3

  • 1Department of General, Visceral and Transplantation Surgery, LMU University Hospital, LMU Munich, Munich, Germany.

Visceral Medicine
|April 9, 2025
PubMed
Abstract

Insights

A 3-day selective digestive decontamination (SDD) regimen is noninferior to a 7-day regimen for preventing surgical site infections in laparoscopic diverticular surgery, though not for anastomotic leakage. This finding supports shorter SDD durations for reducing complications.

Area of Science:

  • Colorectal Surgery
  • Surgical Infections
  • Antibiotic Therapy

Background:

  • Infectious complications like anastomotic leakage (AL) and surgical site infections (SSIs) are significant challenges in colorectal surgery.
  • Selective digestive decontamination (SDD) using nonabsorbable antibiotics is gaining interest to reduce perioperative complications and antibiotic use.

Purpose of the Study:

  • To determine if a 3-day SDD regimen is as effective as a 7-day regimen in preventing postoperative complications in laparoscopic diverticular surgery.

Main Methods:

  • A bicenter data analysis compared 3-day versus 7-day perioperative SDD regimens (polymyxin B, gentamicin, vancomycin, amphotericin B) in patients undergoing minimally invasive surgery for diverticular disease.
  • Noninferiority analysis was used to compare outcomes between the two groups.

Main Results:

  • A total of 469 patients were analyzed (101 in the 3-day group, 368 in the 7-day group).
  • Overall complication rates were 16.5% in both groups.
  • While the 3-day regimen was noninferior for wound infections and overall infectious complications, it was not noninferior for anastomotic leakage (AL).

Conclusions:

  • Minimally invasive surgery for diverticular disease is associated with low complication rates.
  • Perioperative SDD treatment positively impacts SSIs and infectious complications.
  • A 3-day SDD regimen may be a viable alternative to a 7-day regimen for preventing certain complications, but further investigation is needed for AL.

Related Concept Videos

Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
67
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents01:18

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents

Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
101
Endoscopic Procedures IV: Sigmoidoscopy and Laproscopy01:26

Endoscopic Procedures IV: Sigmoidoscopy and Laproscopy

Sigmoidoscopy and laparoscopy are distinct medical procedures that enable physicians to internally inspect different parts of the GI tract. Although they serve different purposes, each is essential for diagnosing and, in some cases, treating various medical conditions.
Sigmoidoscopy
Sigmoidoscopy is a diagnostic procedure that uses a flexible sigmoidoscope equipped with a light source and camera to examine the rectum and sigmoid colon. The procedure involves inserting the tube through the anus...
33
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
126
Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
109
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
253